AstraZeneca

238 results

Traders work on the floor of the New York Stock Exchange on September 11th. Photograph: Michael Nagle/Bloomberg

European shares closed higher on Monday as insurers benefitted from a drop in the estimated cost of Hurricane Irma and investors were relieved that No(...)

Cala Medical founders, from left: Todd Kagawa, Brian Noonan and Jakki Cooney

Sepsis is a serious bloodstream infection. It kills more people than breast cancer, lung cancer and prostate cancer combined. It affects around 26 mil(...)

Iseq heavyweight CRH ending Wednesday 1% lower at €29.16. Its stock has been weak since late May when it was trading at €34.86

Media stocks weighed on European markets on Wednesday, led lower by sharp declines in advertising giant WPP after it cut sales forecasts on weakening (...)

The parent company of Aer Lingus, ICAG, dropped by 0.6 per cent. Photograph: Cyril Byrne

It was a quiet day both in Dublin and across Europe as we came to the end of the summer’s busiest earnings week. Despite thin volumes across the board(...)

Drop in AstraZeneca shares followed a lung cancer drug study failure

The biggest one-day drop in AstraZeneca shares following a drug study failure dominated stock trading in Europe on Thursday, outweighing a handful of (...)

Workers at  AstraZeneca’s  Macclesfield site in England.  Shares in the British drug giant suffered their largest ever fall as it announced a big setback, with a much-awaited trial of a new lung cancer drug failing to show the benefits for which the company had hoped. Photograph: Phil Noble/Reuters

Shares in AstraZeneca were on track to suffer their worst ever fall after the Anglo-Swedish pharmaceutical company suffered a big setback with a much-(...)

GlaxoSmithKline building in Hounslow, west London: GSK, one of Britain’s two Big Pharma firms, decided to abandon plans for a new manufacturing plant in Ulverston in Cumbria. Photograph: Luke MacGregor GlaxoSmithKline building in Hounslow, west London: GSK, one of Britain’s two Big Pharma firms, decided to abandon plans for a new manufacturing plant in Ulverston in Cumbria. Photograph: Luke MacGregor

In a week when the UK’s Eurosceptic international trade minister Liam Fox suggested the British economy could easily manage without a trade deal with (...)

In a half-year trading update, the construction and infrastructure giant Carillion downgraded its full-year revenue guidance, with sales now expected to be between £4.8 billion and £5 billion. Photograph: PA Wire

Markets were down across the board on Tuesday with defensive stocks driving Britain’s FTSE down while the ISEQ’s drop was driven by significant falls (...)

The New York Stock Exchange. The S&P 500 and the Nasdaq Composite were higher in late morning trading on Friday as technology shares rose and oil prices rebounded from multi-month lows.  Photograph: Michael Nagle/Bloomberg

Another wobble in commodity-related shares and dollar earners put pressure on British blue chips on Friday, underscoring their underperformance agains(...)

Pfizer last year failed in its attempt o buy Allergan and move its headquarters to the Republic. Photograph: Bloomberg

Since becoming chief executive of Pfizer in 2010, Ian Read has twice tried to reshape the drugmaker through a transformational acquisition. And twice (...)

  • « First
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Last »